Stroke Trial, Recruiting NCT06660602 Sponsor: China National Center for Cardiovascular Diseases Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06660602
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 80 years of age
  • People who are scheduled to have a heart or blood vessel (cardiovascular) surgery
  • People who are able to understand the trial requirements and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People whose physical condition or health makes it unsafe or impossible to undergo certain required tests, including a CT scan of the neck's blood vessels, a CT scan measuring blood flow in the brain, or a brainwave (EEG) test
  • People with serious kidney problems, such as kidneys that are not filtering blood well enough or blood test results showing significantly reduced kidney function
  • People with serious liver problems, such as abnormal liver blood test results, or conditions including hepatitis, cirrhosis, or other significant liver disease
  • People with other serious health conditions that could affect safe participation in the trial, including alcohol or substance misuse, cancer, or severe problems affecting the liver, kidneys, lungs, hormone system (such as uncontrolled diabetes or thyroid conditions), or blood-producing system
  • People who are unable to follow the trial's procedures due to cognitive, psychological, or physical difficulties
  • People whom the trial investigators consider unsuitable for any medical or other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Shujuan, MD, Chinese Academy of Medical Sciences, Fuwai Hospital

Phone: 18810643595

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
8 February 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Neurological complications within 7 (±3) days post-surgery including fatal or non-fatal stroke, coma, or movement disorders; cognitive dysfunction or delirium

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov